Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudesna Chatterjee

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Trials|October 6, 2018
Physical Activity after Cardiac EventS (PACES) - a group education programme with subsequent text-message support designed to increase physical activity in individuals with diagnosed coronary heart disease: study protocol for a randomised controlled trialLouisa Y Herring, Helen Dallosso, Sudesna Chatterjee, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 4, 2019
Self-Compassion, Metabolic Control and Health Status in Individuals with Type 2 Diabetes: A UK Observational StudyAmy E Morrison, Francesco Zaccardi, Sudesna Chatterjee, et al.
Diabetologia|March 19, 2017
Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validationFrancesco Zaccardi, David R Webb, Melanie J Davies, et al.
Journal of Public Health (Oxford, England)|August 28, 2015
Development of a lifestyle intervention using the MRC framework for diabetes prevention in people with impaired glucose regulationJacqui Troughton, Sudesna Chatterjee, Siân E Hill, et al.
BMJ Open|November 14, 2019
Rationale and design of a cross-sectional study to investigate and describe the chronotype of patients with type 2 diabetes and the effect on glycaemic control: the CODEC studyEmer M Brady, Andrew P Hall, Emma Baldry, et al.
Diabetes, Obesity & Metabolism|April 20, 2022
The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double-blind, placebo-controlled trialJack A Sargeant, James A King, Thomas Yates, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Trials|October 6, 2018
Physical Activity after Cardiac EventS (PACES) - a group education programme with subsequent text-message support designed to increase physical activity in individuals with diagnosed coronary heart disease: study protocol for a randomised controlled trialLouisa Y Herring, Helen Dallosso, Sudesna Chatterjee, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 4, 2019
Self-Compassion, Metabolic Control and Health Status in Individuals with Type 2 Diabetes: A UK Observational StudyAmy E Morrison, Francesco Zaccardi, Sudesna Chatterjee, et al.
Diabetologia|March 19, 2017
Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validationFrancesco Zaccardi, David R Webb, Melanie J Davies, et al.
Journal of Public Health (Oxford, England)|August 28, 2015
Development of a lifestyle intervention using the MRC framework for diabetes prevention in people with impaired glucose regulationJacqui Troughton, Sudesna Chatterjee, Siân E Hill, et al.
BMJ Open|November 14, 2019
Rationale and design of a cross-sectional study to investigate and describe the chronotype of patients with type 2 diabetes and the effect on glycaemic control: the CODEC studyEmer M Brady, Andrew P Hall, Emma Baldry, et al.
Diabetes, Obesity & Metabolism|April 20, 2022
The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double-blind, placebo-controlled trialJack A Sargeant, James A King, Thomas Yates, et al.
Pageof 3